Castle Biosciences, Inc.
CSTL
$18.63
-$0.41-2.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.89% | 2.17% | 2.77% | 6.25% | 15.02% |
| Total Receivables | -23.51% | -14.16% | 0.84% | 15.92% | 33.38% |
| Inventory | 52.74% | 26.05% | 31.62% | 4.41% | -10.41% |
| Prepaid Expenses | 26.41% | -3.04% | 31.16% | 64.70% | 67.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.86% | 0.26% | 3.71% | 8.82% | 18.13% |
|
|
|||||
| Total Current Assets | -5.86% | 0.26% | 3.71% | 8.82% | 18.13% |
| Net Property, Plant & Equipment | 73.24% | 78.99% | 77.72% | 78.20% | 48.42% |
| Long-term Investments | -0.01% | 0.00% | -0.01% | 0.01% | 0.00% |
| Goodwill | -0.01% | 0.00% | -0.01% | 0.01% | 0.00% |
| Total Other Intangibles | 28.93% | -6.97% | -8.73% | -8.53% | -35.62% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 173.57% | 163.14% | 13.45% | -37.68% | -18.37% |
| Total Assets | 9.19% | 8.91% | 9.37% | 11.78% | 9.42% |
|
|
|||||
| Total Accounts Payable | 76.88% | 171.13% | 79.31% | 38.17% | -8.76% |
| Total Accrued Expenses | 9.92% | 16.54% | 7.70% | 12.26% | 14.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.73% | -9.78% | -16.96% | 186.70% | 114.13% |
| Total Finance Division Other Current Liabilities | 90.46% | 72.90% | 500.63% | 220.63% | 220.10% |
| Total Other Current Liabilities | 90.46% | 72.90% | 500.63% | 220.63% | 220.10% |
| Total Current Liabilities | 30.82% | 39.04% | 24.86% | 28.99% | 16.63% |
|
|
|||||
| Total Current Liabilities | 30.82% | 39.04% | 24.86% | 28.99% | 16.63% |
| Long-Term Debt | -5.85% | -1.08% | 0.34% | -19.10% | -10.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 76.70% | 74.20% | 71.17% | 84.43% | 3.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 356.99% | 138.64% | 12.37% | -- | 306.31% |
| Total Liabilities | 40.68% | 42.82% | 30.24% | 40.89% | 9.57% |
|
|
|||||
| Common Stock & APIC | 5.12% | 5.97% | 5.91% | 6.40% | 6.84% |
| Retained Earnings | -5.68% | -12.07% | -5.83% | -4.47% | -2.29% |
| Treasury Stock & Other | -148.09% | 16.09% | -49.26% | 122.67% | 218.02% |
| Total Common Equity | 4.79% | 3.30% | 5.89% | 7.43% | 9.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.79% | 3.30% | 5.89% | 7.43% | 9.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.79% | 3.30% | 5.89% | 7.43% | 9.40% |
|
|
|||||